Bioray Biotech Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2020
April 22, 2021 at 09:54 am EDT
Share
Bioray Biotech Co. Ltd. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was TWD 156.295 million compared to TWD 181.932 million a year ago. Operating loss was TWD 222,000 compared to operating Income of TWD 6.849 million a year ago. Net loss was TWD 58,000 compared to net income of TWD 19.488 million a year ago. Basic eps - continuing operations was TWD 0 compared to TWD 0.73 a year ago.
Bioray Biotech Co Ltd is a Taiwan-based company mainly engaged in the production of health products, as well as the Own Designing & Manufacturing and Original Equipment Manufacturing (ODM/OEM) business. The Company also provides functional medical testing services, as well as cell storage and preparations business. The health products include personalized probiotics, anti-allergic and intestinal probiotics, diabetes probiotics, female urinary tract, anti-arthritis probiotics, among others. The testing services include personalized bacteria, personalized fungi, intestinal normal bacteria, quantitative detection of magnesium in red blood cells, polymorphism analysis of metabolic related genes, lymphocyte grouping. The cell storage and preparations include stem cell storage, immune cell storage, cytokine induced killer (CIK) immune cell preparations, among others.
BIORAY BIOTECH CO., LTD 
